The optimal 18F-Fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth.


Journal article


Inna Gertsenshteyn, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, Erica Markiewicz, Hsui-Ming Tsai, Subramanian Sundramoorthy, Lara Leoni, John Lukens, Mohammed Bhuiyan, Richard Freifelder, Anna Kucharski, Mihai Giurcanu, Gregory Karczmar Brian Roman, Chien-Min Kao, Howard Halpern, Chin-Tu Chen
European Journal of Nuclear Medicine and Molecular Imaging, 2022


View PDF SharedIt Link
Cite

Cite

APA
Gertsenshteyn, I., Epel, B., Ahluwalia, A., Kim, H., Fan, X., Barth, E., … Chen, C.-T. (2022). The optimal 18F-Fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth. European Journal of Nuclear Medicine and Molecular Imaging.

Chicago/Turabian
Gertsenshteyn, Inna, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, et al. “The Optimal 18F-Fluoromisonidazole PET Threshold to Define Tumor Hypoxia in Preclinical Squamous Cell Carcinomas Using pO2 Electron Paramagnetic Resonance Imaging as Reference Truth.” European Journal of Nuclear Medicine and Molecular Imaging (2022).

MLA
Gertsenshteyn, Inna, et al. “The Optimal 18F-Fluoromisonidazole PET Threshold to Define Tumor Hypoxia in Preclinical Squamous Cell Carcinomas Using pO2 Electron Paramagnetic Resonance Imaging as Reference Truth.” European Journal of Nuclear Medicine and Molecular Imaging, 2022.


Share